Histamine H1 receptor antagonist cetirizine impairs working memory processing speed, but not episodic memory

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)

Abstract

BACKGROUND AND PURPOSE: The histaminergic neurotransmitter system is currently under investigation as a target for drug treatment of cognitive deficits in clinical disorders. The therapeutic potential of new drugs may initially be screened using a model of histaminergic dysfunction, for example, as associated with the use of centrally active antihistamines. Of the selective second generation antihistamines, cetirizine has been found to have central nervous system effects. The aim of the present study was to determine whether cetirizine can be used as a tool to model cognitive deficits associated with histaminergic hypofunction. EXPERIMENTAL APPROACH: The study was conducted according to a three-way, double-blind, cross-over design. Treatments were single oral doses of cetirizine 10 and 20 mg and placebo. Effects on cognition were assessed using tests of word learning, memory scanning, vigilance, divided attention, tracking and visual information processing speed. KEY RESULTS: Cetirizine 10 mg impaired tracking performance and both doses impaired memory scanning speed. None of the other measures indicated impaired performance. CONCLUSION AND IMPLICATIONS: Cetirizine affects information processing speed, but these effects were not sufficient to serve as a model for cognitive deficits in clinical disorders.
Original languageEnglish
Pages (from-to)456-466
Number of pages11
JournalBritish Journal of Pharmacology
Volume161
Issue number2
DOIs
Publication statusPublished - Sep 2010

Keywords

  • ANTIHISTAMINES
  • BRAIN HISTAMINE
  • DEXCHLORPHENIRAMINE
  • DIPHENHYDRAMINE
  • FEXOFENADINE
  • MEQUITAZINE
  • OCCUPANCY
  • PSYCHOMETRIC TEST-PERFORMANCE
  • PSYCHOMOTOR PERFORMANCE
  • SEDATION
  • antihistamine
  • cetirizine
  • episodic memory
  • psychomotor performance
  • working memory

Cite this

@article{176c473cf81b4dae82546e16acee3614,
title = "Histamine H1 receptor antagonist cetirizine impairs working memory processing speed, but not episodic memory",
abstract = "BACKGROUND AND PURPOSE: The histaminergic neurotransmitter system is currently under investigation as a target for drug treatment of cognitive deficits in clinical disorders. The therapeutic potential of new drugs may initially be screened using a model of histaminergic dysfunction, for example, as associated with the use of centrally active antihistamines. Of the selective second generation antihistamines, cetirizine has been found to have central nervous system effects. The aim of the present study was to determine whether cetirizine can be used as a tool to model cognitive deficits associated with histaminergic hypofunction. EXPERIMENTAL APPROACH: The study was conducted according to a three-way, double-blind, cross-over design. Treatments were single oral doses of cetirizine 10 and 20 mg and placebo. Effects on cognition were assessed using tests of word learning, memory scanning, vigilance, divided attention, tracking and visual information processing speed. KEY RESULTS: Cetirizine 10 mg impaired tracking performance and both doses impaired memory scanning speed. None of the other measures indicated impaired performance. CONCLUSION AND IMPLICATIONS: Cetirizine affects information processing speed, but these effects were not sufficient to serve as a model for cognitive deficits in clinical disorders.",
keywords = "ANTIHISTAMINES, BRAIN HISTAMINE, DEXCHLORPHENIRAMINE, DIPHENHYDRAMINE, FEXOFENADINE, MEQUITAZINE, OCCUPANCY, PSYCHOMETRIC TEST-PERFORMANCE, PSYCHOMOTOR PERFORMANCE, SEDATION, antihistamine, cetirizine, episodic memory, psychomotor performance, working memory",
author = "{van Ruitenbeek}, P. and A. Vermeeren and W.J. Riedel",
year = "2010",
month = "9",
doi = "10.1111/j.1476-5381.2010.00907.x",
language = "English",
volume = "161",
pages = "456--466",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley",
number = "2",

}

Histamine H1 receptor antagonist cetirizine impairs working memory processing speed, but not episodic memory. / van Ruitenbeek, P.; Vermeeren, A.; Riedel, W.J.

In: British Journal of Pharmacology, Vol. 161, No. 2, 09.2010, p. 456-466.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Histamine H1 receptor antagonist cetirizine impairs working memory processing speed, but not episodic memory

AU - van Ruitenbeek, P.

AU - Vermeeren, A.

AU - Riedel, W.J.

PY - 2010/9

Y1 - 2010/9

N2 - BACKGROUND AND PURPOSE: The histaminergic neurotransmitter system is currently under investigation as a target for drug treatment of cognitive deficits in clinical disorders. The therapeutic potential of new drugs may initially be screened using a model of histaminergic dysfunction, for example, as associated with the use of centrally active antihistamines. Of the selective second generation antihistamines, cetirizine has been found to have central nervous system effects. The aim of the present study was to determine whether cetirizine can be used as a tool to model cognitive deficits associated with histaminergic hypofunction. EXPERIMENTAL APPROACH: The study was conducted according to a three-way, double-blind, cross-over design. Treatments were single oral doses of cetirizine 10 and 20 mg and placebo. Effects on cognition were assessed using tests of word learning, memory scanning, vigilance, divided attention, tracking and visual information processing speed. KEY RESULTS: Cetirizine 10 mg impaired tracking performance and both doses impaired memory scanning speed. None of the other measures indicated impaired performance. CONCLUSION AND IMPLICATIONS: Cetirizine affects information processing speed, but these effects were not sufficient to serve as a model for cognitive deficits in clinical disorders.

AB - BACKGROUND AND PURPOSE: The histaminergic neurotransmitter system is currently under investigation as a target for drug treatment of cognitive deficits in clinical disorders. The therapeutic potential of new drugs may initially be screened using a model of histaminergic dysfunction, for example, as associated with the use of centrally active antihistamines. Of the selective second generation antihistamines, cetirizine has been found to have central nervous system effects. The aim of the present study was to determine whether cetirizine can be used as a tool to model cognitive deficits associated with histaminergic hypofunction. EXPERIMENTAL APPROACH: The study was conducted according to a three-way, double-blind, cross-over design. Treatments were single oral doses of cetirizine 10 and 20 mg and placebo. Effects on cognition were assessed using tests of word learning, memory scanning, vigilance, divided attention, tracking and visual information processing speed. KEY RESULTS: Cetirizine 10 mg impaired tracking performance and both doses impaired memory scanning speed. None of the other measures indicated impaired performance. CONCLUSION AND IMPLICATIONS: Cetirizine affects information processing speed, but these effects were not sufficient to serve as a model for cognitive deficits in clinical disorders.

KW - ANTIHISTAMINES

KW - BRAIN HISTAMINE

KW - DEXCHLORPHENIRAMINE

KW - DIPHENHYDRAMINE

KW - FEXOFENADINE

KW - MEQUITAZINE

KW - OCCUPANCY

KW - PSYCHOMETRIC TEST-PERFORMANCE

KW - PSYCHOMOTOR PERFORMANCE

KW - SEDATION

KW - antihistamine

KW - cetirizine

KW - episodic memory

KW - psychomotor performance

KW - working memory

U2 - 10.1111/j.1476-5381.2010.00907.x

DO - 10.1111/j.1476-5381.2010.00907.x

M3 - Article

VL - 161

SP - 456

EP - 466

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 2

ER -